Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Risk of new-onset hair loss with semaglutide and tirzepatide: A TriNetX cohort study. | Pepdox

Home
Search
PMID 41707704

Risk of new-onset hair loss with semaglutide and tirzepatide: A TriNetX cohort study.

Journal of the American Academy of Dermatology2026PMID: 41707704

View on PubMed DOI: 10.1016/j.jaad.2026.02.042

Semaglutide Tirzepatide

Authors

Herrera, Henry O; Bordeaux, Jeremy S

Keywords

GLP-1 receptor agonistalopeciaandrogenetic alopeciaelectronic health recordshair losssemaglutidetelogen effluviumtirzepatide